Patent · US Active

Anti-interleukin-33 antibodies and uses thereof

US11725050B2 · kind B2 · utility

1Cited by
13References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2020
Grant dateAug 15, 2023
Priority date—
Expiry dateAug 1, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.